The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Computer-assisted Drug Design Platform Market Research Report 2025
Synopsis
The global Computer-assisted Drug Design Platform market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Computer-assisted Drug Design Platform is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Computer-assisted Drug Design Platform is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Computer-assisted Drug Design Platform in Drug Discovery and Development is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Computer-assisted Drug Design Platform include Entelos, Crown Bioscience, Chemical Computing Group, Nimbus Therapeutics, Schrodinger, Dassault Systemes, Genedata, Biognos and Leadscope, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Computer-assisted Drug Design Platform, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Computer-assisted Drug Design Platform.
Report Scope
The Computer-assisted Drug Design Platform market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Computer-assisted Drug Design Platform market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Computer-assisted Drug Design Platform companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Entelos
Crown Bioscience
Chemical Computing Group
Nimbus Therapeutics
Schrodinger
Dassault Systemes
Genedata
Biognos
Leadscope
Rhenovia Pharma Limited
Compugen
Certara LP
Prosarix
Simulations Plus
Strand Life Sciences
Segment by Type
Cloud-based
On-premise
Segment by Application
Drug Discovery and Development
Computational Physiological Medicine
Disease Modeling
Medical Imaging
Predictive Analysis of Drug Targets
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Computer-assisted Drug Design Platform companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Computer-assisted Drug Design Platform market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Computer-assisted Drug Design Platform is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Computer-assisted Drug Design Platform is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Computer-assisted Drug Design Platform in Drug Discovery and Development is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Computer-assisted Drug Design Platform include Entelos, Crown Bioscience, Chemical Computing Group, Nimbus Therapeutics, Schrodinger, Dassault Systemes, Genedata, Biognos and Leadscope, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Computer-assisted Drug Design Platform, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Computer-assisted Drug Design Platform.
Report Scope
The Computer-assisted Drug Design Platform market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Computer-assisted Drug Design Platform market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Computer-assisted Drug Design Platform companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Entelos
Crown Bioscience
Chemical Computing Group
Nimbus Therapeutics
Schrodinger
Dassault Systemes
Genedata
Biognos
Leadscope
Rhenovia Pharma Limited
Compugen
Certara LP
Prosarix
Simulations Plus
Strand Life Sciences
Segment by Type
Cloud-based
On-premise
Segment by Application
Drug Discovery and Development
Computational Physiological Medicine
Disease Modeling
Medical Imaging
Predictive Analysis of Drug Targets
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Computer-assisted Drug Design Platform companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Computer-assisted Drug Design Platform Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cloud-based
1.2.3 On-premise
1.3 Market by Application
1.3.1 Global Computer-assisted Drug Design Platform Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Drug Discovery and Development
1.3.3 Computational Physiological Medicine
1.3.4 Disease Modeling
1.3.5 Medical Imaging
1.3.6 Predictive Analysis of Drug Targets
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Computer-assisted Drug Design Platform Market Perspective (2019-2030)
2.2 Computer-assisted Drug Design Platform Growth Trends by Region
2.2.1 Global Computer-assisted Drug Design Platform Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Computer-assisted Drug Design Platform Historic Market Size by Region (2019-2024)
2.2.3 Computer-assisted Drug Design Platform Forecasted Market Size by Region (2025-2030)
2.3 Computer-assisted Drug Design Platform Market Dynamics
2.3.1 Computer-assisted Drug Design Platform Industry Trends
2.3.2 Computer-assisted Drug Design Platform Market Drivers
2.3.3 Computer-assisted Drug Design Platform Market Challenges
2.3.4 Computer-assisted Drug Design Platform Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Computer-assisted Drug Design Platform Players by Revenue
3.1.1 Global Top Computer-assisted Drug Design Platform Players by Revenue (2019-2024)
3.1.2 Global Computer-assisted Drug Design Platform Revenue Market Share by Players (2019-2024)
3.2 Global Computer-assisted Drug Design Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Computer-assisted Drug Design Platform Revenue
3.4 Global Computer-assisted Drug Design Platform Market Concentration Ratio
3.4.1 Global Computer-assisted Drug Design Platform Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Computer-assisted Drug Design Platform Revenue in 2023
3.5 Computer-assisted Drug Design Platform Key Players Head office and Area Served
3.6 Key Players Computer-assisted Drug Design Platform Product Solution and Service
3.7 Date of Enter into Computer-assisted Drug Design Platform Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Computer-assisted Drug Design Platform Breakdown Data by Type
4.1 Global Computer-assisted Drug Design Platform Historic Market Size by Type (2019-2024)
4.2 Global Computer-assisted Drug Design Platform Forecasted Market Size by Type (2025-2030)
5 Computer-assisted Drug Design Platform Breakdown Data by Application
5.1 Global Computer-assisted Drug Design Platform Historic Market Size by Application (2019-2024)
5.2 Global Computer-assisted Drug Design Platform Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Computer-assisted Drug Design Platform Market Size (2019-2030)
6.2 North America Computer-assisted Drug Design Platform Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Computer-assisted Drug Design Platform Market Size by Country (2019-2024)
6.4 North America Computer-assisted Drug Design Platform Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Computer-assisted Drug Design Platform Market Size (2019-2030)
7.2 Europe Computer-assisted Drug Design Platform Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Computer-assisted Drug Design Platform Market Size by Country (2019-2024)
7.4 Europe Computer-assisted Drug Design Platform Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Computer-assisted Drug Design Platform Market Size (2019-2030)
8.2 Asia-Pacific Computer-assisted Drug Design Platform Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Computer-assisted Drug Design Platform Market Size by Region (2019-2024)
8.4 Asia-Pacific Computer-assisted Drug Design Platform Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Computer-assisted Drug Design Platform Market Size (2019-2030)
9.2 Latin America Computer-assisted Drug Design Platform Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Computer-assisted Drug Design Platform Market Size by Country (2019-2024)
9.4 Latin America Computer-assisted Drug Design Platform Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Computer-assisted Drug Design Platform Market Size (2019-2030)
10.2 Middle East & Africa Computer-assisted Drug Design Platform Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Computer-assisted Drug Design Platform Market Size by Country (2019-2024)
10.4 Middle East & Africa Computer-assisted Drug Design Platform Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Entelos
11.1.1 Entelos Company Detail
11.1.2 Entelos Business Overview
11.1.3 Entelos Computer-assisted Drug Design Platform Introduction
11.1.4 Entelos Revenue in Computer-assisted Drug Design Platform Business (2019-2024)
11.1.5 Entelos Recent Development
11.2 Crown Bioscience
11.2.1 Crown Bioscience Company Detail
11.2.2 Crown Bioscience Business Overview
11.2.3 Crown Bioscience Computer-assisted Drug Design Platform Introduction
11.2.4 Crown Bioscience Revenue in Computer-assisted Drug Design Platform Business (2019-2024)
11.2.5 Crown Bioscience Recent Development
11.3 Chemical Computing Group
11.3.1 Chemical Computing Group Company Detail
11.3.2 Chemical Computing Group Business Overview
11.3.3 Chemical Computing Group Computer-assisted Drug Design Platform Introduction
11.3.4 Chemical Computing Group Revenue in Computer-assisted Drug Design Platform Business (2019-2024)
11.3.5 Chemical Computing Group Recent Development
11.4 Nimbus Therapeutics
11.4.1 Nimbus Therapeutics Company Detail
11.4.2 Nimbus Therapeutics Business Overview
11.4.3 Nimbus Therapeutics Computer-assisted Drug Design Platform Introduction
11.4.4 Nimbus Therapeutics Revenue in Computer-assisted Drug Design Platform Business (2019-2024)
11.4.5 Nimbus Therapeutics Recent Development
11.5 Schrodinger
11.5.1 Schrodinger Company Detail
11.5.2 Schrodinger Business Overview
11.5.3 Schrodinger Computer-assisted Drug Design Platform Introduction
11.5.4 Schrodinger Revenue in Computer-assisted Drug Design Platform Business (2019-2024)
11.5.5 Schrodinger Recent Development
11.6 Dassault Systemes
11.6.1 Dassault Systemes Company Detail
11.6.2 Dassault Systemes Business Overview
11.6.3 Dassault Systemes Computer-assisted Drug Design Platform Introduction
11.6.4 Dassault Systemes Revenue in Computer-assisted Drug Design Platform Business (2019-2024)
11.6.5 Dassault Systemes Recent Development
11.7 Genedata
11.7.1 Genedata Company Detail
11.7.2 Genedata Business Overview
11.7.3 Genedata Computer-assisted Drug Design Platform Introduction
11.7.4 Genedata Revenue in Computer-assisted Drug Design Platform Business (2019-2024)
11.7.5 Genedata Recent Development
11.8 Biognos
11.8.1 Biognos Company Detail
11.8.2 Biognos Business Overview
11.8.3 Biognos Computer-assisted Drug Design Platform Introduction
11.8.4 Biognos Revenue in Computer-assisted Drug Design Platform Business (2019-2024)
11.8.5 Biognos Recent Development
11.9 Leadscope
11.9.1 Leadscope Company Detail
11.9.2 Leadscope Business Overview
11.9.3 Leadscope Computer-assisted Drug Design Platform Introduction
11.9.4 Leadscope Revenue in Computer-assisted Drug Design Platform Business (2019-2024)
11.9.5 Leadscope Recent Development
11.10 Rhenovia Pharma Limited
11.10.1 Rhenovia Pharma Limited Company Detail
11.10.2 Rhenovia Pharma Limited Business Overview
11.10.3 Rhenovia Pharma Limited Computer-assisted Drug Design Platform Introduction
11.10.4 Rhenovia Pharma Limited Revenue in Computer-assisted Drug Design Platform Business (2019-2024)
11.10.5 Rhenovia Pharma Limited Recent Development
11.11 Compugen
11.11.1 Compugen Company Detail
11.11.2 Compugen Business Overview
11.11.3 Compugen Computer-assisted Drug Design Platform Introduction
11.11.4 Compugen Revenue in Computer-assisted Drug Design Platform Business (2019-2024)
11.11.5 Compugen Recent Development
11.12 Certara LP
11.12.1 Certara LP Company Detail
11.12.2 Certara LP Business Overview
11.12.3 Certara LP Computer-assisted Drug Design Platform Introduction
11.12.4 Certara LP Revenue in Computer-assisted Drug Design Platform Business (2019-2024)
11.12.5 Certara LP Recent Development
11.13 Prosarix
11.13.1 Prosarix Company Detail
11.13.2 Prosarix Business Overview
11.13.3 Prosarix Computer-assisted Drug Design Platform Introduction
11.13.4 Prosarix Revenue in Computer-assisted Drug Design Platform Business (2019-2024)
11.13.5 Prosarix Recent Development
11.14 Simulations Plus
11.14.1 Simulations Plus Company Detail
11.14.2 Simulations Plus Business Overview
11.14.3 Simulations Plus Computer-assisted Drug Design Platform Introduction
11.14.4 Simulations Plus Revenue in Computer-assisted Drug Design Platform Business (2019-2024)
11.14.5 Simulations Plus Recent Development
11.15 Strand Life Sciences
11.15.1 Strand Life Sciences Company Detail
11.15.2 Strand Life Sciences Business Overview
11.15.3 Strand Life Sciences Computer-assisted Drug Design Platform Introduction
11.15.4 Strand Life Sciences Revenue in Computer-assisted Drug Design Platform Business (2019-2024)
11.15.5 Strand Life Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Computer-assisted Drug Design Platform Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Cloud-based
Table 3. Key Players of On-premise
Table 4. Global Computer-assisted Drug Design Platform Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Computer-assisted Drug Design Platform Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Computer-assisted Drug Design Platform Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Computer-assisted Drug Design Platform Market Share by Region (2019-2024)
Table 8. Global Computer-assisted Drug Design Platform Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Computer-assisted Drug Design Platform Market Share by Region (2025-2030)
Table 10. Computer-assisted Drug Design Platform Market Trends
Table 11. Computer-assisted Drug Design Platform Market Drivers
Table 12. Computer-assisted Drug Design Platform Market Challenges
Table 13. Computer-assisted Drug Design Platform Market Restraints
Table 14. Global Computer-assisted Drug Design Platform Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Computer-assisted Drug Design Platform Market Share by Players (2019-2024)
Table 16. Global Top Computer-assisted Drug Design Platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Computer-assisted Drug Design Platform as of 2023)
Table 17. Ranking of Global Top Computer-assisted Drug Design Platform Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Computer-assisted Drug Design Platform Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Computer-assisted Drug Design Platform Product Solution and Service
Table 21. Date of Enter into Computer-assisted Drug Design Platform Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Computer-assisted Drug Design Platform Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Computer-assisted Drug Design Platform Revenue Market Share by Type (2019-2024)
Table 25. Global Computer-assisted Drug Design Platform Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Computer-assisted Drug Design Platform Revenue Market Share by Type (2025-2030)
Table 27. Global Computer-assisted Drug Design Platform Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Computer-assisted Drug Design Platform Revenue Market Share by Application (2019-2024)
Table 29. Global Computer-assisted Drug Design Platform Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Computer-assisted Drug Design Platform Revenue Market Share by Application (2025-2030)
Table 31. North America Computer-assisted Drug Design Platform Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Computer-assisted Drug Design Platform Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Computer-assisted Drug Design Platform Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Computer-assisted Drug Design Platform Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Computer-assisted Drug Design Platform Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Computer-assisted Drug Design Platform Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Computer-assisted Drug Design Platform Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Computer-assisted Drug Design Platform Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Computer-assisted Drug Design Platform Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Computer-assisted Drug Design Platform Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Computer-assisted Drug Design Platform Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Computer-assisted Drug Design Platform Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Computer-assisted Drug Design Platform Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Computer-assisted Drug Design Platform Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Computer-assisted Drug Design Platform Market Size by Country (2025-2030) & (US$ Million)
Table 46. Entelos Company Detail
Table 47. Entelos Business Overview
Table 48. Entelos Computer-assisted Drug Design Platform Product
Table 49. Entelos Revenue in Computer-assisted Drug Design Platform Business (2019-2024) & (US$ Million)
Table 50. Entelos Recent Development
Table 51. Crown Bioscience Company Detail
Table 52. Crown Bioscience Business Overview
Table 53. Crown Bioscience Computer-assisted Drug Design Platform Product
Table 54. Crown Bioscience Revenue in Computer-assisted Drug Design Platform Business (2019-2024) & (US$ Million)
Table 55. Crown Bioscience Recent Development
Table 56. Chemical Computing Group Company Detail
Table 57. Chemical Computing Group Business Overview
Table 58. Chemical Computing Group Computer-assisted Drug Design Platform Product
Table 59. Chemical Computing Group Revenue in Computer-assisted Drug Design Platform Business (2019-2024) & (US$ Million)
Table 60. Chemical Computing Group Recent Development
Table 61. Nimbus Therapeutics Company Detail
Table 62. Nimbus Therapeutics Business Overview
Table 63. Nimbus Therapeutics Computer-assisted Drug Design Platform Product
Table 64. Nimbus Therapeutics Revenue in Computer-assisted Drug Design Platform Business (2019-2024) & (US$ Million)
Table 65. Nimbus Therapeutics Recent Development
Table 66. Schrodinger Company Detail
Table 67. Schrodinger Business Overview
Table 68. Schrodinger Computer-assisted Drug Design Platform Product
Table 69. Schrodinger Revenue in Computer-assisted Drug Design Platform Business (2019-2024) & (US$ Million)
Table 70. Schrodinger Recent Development
Table 71. Dassault Systemes Company Detail
Table 72. Dassault Systemes Business Overview
Table 73. Dassault Systemes Computer-assisted Drug Design Platform Product
Table 74. Dassault Systemes Revenue in Computer-assisted Drug Design Platform Business (2019-2024) & (US$ Million)
Table 75. Dassault Systemes Recent Development
Table 76. Genedata Company Detail
Table 77. Genedata Business Overview
Table 78. Genedata Computer-assisted Drug Design Platform Product
Table 79. Genedata Revenue in Computer-assisted Drug Design Platform Business (2019-2024) & (US$ Million)
Table 80. Genedata Recent Development
Table 81. Biognos Company Detail
Table 82. Biognos Business Overview
Table 83. Biognos Computer-assisted Drug Design Platform Product
Table 84. Biognos Revenue in Computer-assisted Drug Design Platform Business (2019-2024) & (US$ Million)
Table 85. Biognos Recent Development
Table 86. Leadscope Company Detail
Table 87. Leadscope Business Overview
Table 88. Leadscope Computer-assisted Drug Design Platform Product
Table 89. Leadscope Revenue in Computer-assisted Drug Design Platform Business (2019-2024) & (US$ Million)
Table 90. Leadscope Recent Development
Table 91. Rhenovia Pharma Limited Company Detail
Table 92. Rhenovia Pharma Limited Business Overview
Table 93. Rhenovia Pharma Limited Computer-assisted Drug Design Platform Product
Table 94. Rhenovia Pharma Limited Revenue in Computer-assisted Drug Design Platform Business (2019-2024) & (US$ Million)
Table 95. Rhenovia Pharma Limited Recent Development
Table 96. Compugen Company Detail
Table 97. Compugen Business Overview
Table 98. Compugen Computer-assisted Drug Design Platform Product
Table 99. Compugen Revenue in Computer-assisted Drug Design Platform Business (2019-2024) & (US$ Million)
Table 100. Compugen Recent Development
Table 101. Certara LP Company Detail
Table 102. Certara LP Business Overview
Table 103. Certara LP Computer-assisted Drug Design Platform Product
Table 104. Certara LP Revenue in Computer-assisted Drug Design Platform Business (2019-2024) & (US$ Million)
Table 105. Certara LP Recent Development
Table 106. Prosarix Company Detail
Table 107. Prosarix Business Overview
Table 108. Prosarix Computer-assisted Drug Design Platform Product
Table 109. Prosarix Revenue in Computer-assisted Drug Design Platform Business (2019-2024) & (US$ Million)
Table 110. Prosarix Recent Development
Table 111. Simulations Plus Company Detail
Table 112. Simulations Plus Business Overview
Table 113. Simulations Plus Computer-assisted Drug Design Platform Product
Table 114. Simulations Plus Revenue in Computer-assisted Drug Design Platform Business (2019-2024) & (US$ Million)
Table 115. Simulations Plus Recent Development
Table 116. Strand Life Sciences Company Detail
Table 117. Strand Life Sciences Business Overview
Table 118. Strand Life Sciences Computer-assisted Drug Design Platform Product
Table 119. Strand Life Sciences Revenue in Computer-assisted Drug Design Platform Business (2019-2024) & (US$ Million)
Table 120. Strand Life Sciences Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Computer-assisted Drug Design Platform Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Computer-assisted Drug Design Platform Market Share by Type: 2023 VS 2030
Figure 3. Cloud-based Features
Figure 4. On-premise Features
Figure 5. Global Computer-assisted Drug Design Platform Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Computer-assisted Drug Design Platform Market Share by Application: 2023 VS 2030
Figure 7. Drug Discovery and Development Case Studies
Figure 8. Computational Physiological Medicine Case Studies
Figure 9. Disease Modeling Case Studies
Figure 10. Medical Imaging Case Studies
Figure 11. Predictive Analysis of Drug Targets Case Studies
Figure 12. Computer-assisted Drug Design Platform Report Years Considered
Figure 13. Global Computer-assisted Drug Design Platform Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Computer-assisted Drug Design Platform Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Computer-assisted Drug Design Platform Market Share by Region: 2023 VS 2030
Figure 16. Global Computer-assisted Drug Design Platform Market Share by Players in 2023
Figure 17. Global Top Computer-assisted Drug Design Platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Computer-assisted Drug Design Platform as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Computer-assisted Drug Design Platform Revenue in 2023
Figure 19. North America Computer-assisted Drug Design Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Computer-assisted Drug Design Platform Market Share by Country (2019-2030)
Figure 21. United States Computer-assisted Drug Design Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Computer-assisted Drug Design Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Computer-assisted Drug Design Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Computer-assisted Drug Design Platform Market Share by Country (2019-2030)
Figure 25. Germany Computer-assisted Drug Design Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Computer-assisted Drug Design Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Computer-assisted Drug Design Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Computer-assisted Drug Design Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Computer-assisted Drug Design Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Computer-assisted Drug Design Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Computer-assisted Drug Design Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Computer-assisted Drug Design Platform Market Share by Region (2019-2030)
Figure 33. China Computer-assisted Drug Design Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Computer-assisted Drug Design Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Computer-assisted Drug Design Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Computer-assisted Drug Design Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Computer-assisted Drug Design Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Computer-assisted Drug Design Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Computer-assisted Drug Design Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Computer-assisted Drug Design Platform Market Share by Country (2019-2030)
Figure 41. Mexico Computer-assisted Drug Design Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Computer-assisted Drug Design Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Computer-assisted Drug Design Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Computer-assisted Drug Design Platform Market Share by Country (2019-2030)
Figure 45. Turkey Computer-assisted Drug Design Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Computer-assisted Drug Design Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Entelos Revenue Growth Rate in Computer-assisted Drug Design Platform Business (2019-2024)
Figure 48. Crown Bioscience Revenue Growth Rate in Computer-assisted Drug Design Platform Business (2019-2024)
Figure 49. Chemical Computing Group Revenue Growth Rate in Computer-assisted Drug Design Platform Business (2019-2024)
Figure 50. Nimbus Therapeutics Revenue Growth Rate in Computer-assisted Drug Design Platform Business (2019-2024)
Figure 51. Schrodinger Revenue Growth Rate in Computer-assisted Drug Design Platform Business (2019-2024)
Figure 52. Dassault Systemes Revenue Growth Rate in Computer-assisted Drug Design Platform Business (2019-2024)
Figure 53. Genedata Revenue Growth Rate in Computer-assisted Drug Design Platform Business (2019-2024)
Figure 54. Biognos Revenue Growth Rate in Computer-assisted Drug Design Platform Business (2019-2024)
Figure 55. Leadscope Revenue Growth Rate in Computer-assisted Drug Design Platform Business (2019-2024)
Figure 56. Rhenovia Pharma Limited Revenue Growth Rate in Computer-assisted Drug Design Platform Business (2019-2024)
Figure 57. Compugen Revenue Growth Rate in Computer-assisted Drug Design Platform Business (2019-2024)
Figure 58. Certara LP Revenue Growth Rate in Computer-assisted Drug Design Platform Business (2019-2024)
Figure 59. Prosarix Revenue Growth Rate in Computer-assisted Drug Design Platform Business (2019-2024)
Figure 60. Simulations Plus Revenue Growth Rate in Computer-assisted Drug Design Platform Business (2019-2024)
Figure 61. Strand Life Sciences Revenue Growth Rate in Computer-assisted Drug Design Platform Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
